Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Microsaic Systems (MSYS) by Steve Moore in ShareProphets
- Avoid Aptamer Group (APTA) by Steve Moore in ShareProphets
- Avoid Transense Technologies (TRT) by Steve Moore in ShareProphets
- Outperform Linde (0M2B) by Bernstein
- Avoid Boohoo Group (BOO) by Steve Moore in ShareProphets
- Watch Raspberry PI Holdings (RPI) by Edward Sheldon in The Motley Fool
- Buy Antofagasta (ANTO) by Bank of America
- Outperform Relx plc (REL) by ODDO BHF
- Outperform Chesnara (CSN) by RBC Capital
- Buy Yellow Cake (YCA) by Berenberg
- Outperform NextEnergy Solar Fund Limited Red (NESF) by RBC Capital
- Buy Applied Nutrition (APN) by Deutsche Bank
- Neutral Legal & General Group (LGEN) by Exane
- Hold Unilever (ULVR) by Kepler Cheuvreux
- Hold Unilever (ULVR) by Berenberg
- Neutral NATWEST GROUP (NWG) by Goldman Sachs
- Buy Antofagasta (ANTO) by Goldman Sachs
- Overweight Molten Ventures (GROW) by Barclays
- Buy Melrose Industries (MRO) by Citi
- Buy AstraZeneca (AZN) by Berenberg
Indivior (INDV) Share Price
Health Care Sector
NOTE: This is based on 102 open tips for Indivior (INDV)
| Latest Bid : 1,248.00p | Latest Ask : 1,250.00p |
| High Today : 1,264.00p | Low Today : 1,230.00p |
| This Years High : 1,264.00p | This Years Low : 576.50p |
| Volume : 304,722 | MKT Cap : £1547.5M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Indivior (INDV) Overview
Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.Indivior (INDV) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Sabah Meddings | Premium Only | 2021-10-24 09:30:00 24/10/2021 | -38.67% |
| Buy | Kevin Godbold | Premium Only | 2021-10-16 09:40:00 16/10/2021 | -45.82% |
| Buy | Jefferies | Premium Only | 2021-08-31 05:11:00 31/08/2021 | 33.78% |
| Buy | Royston Wild | Premium Only | 2021-07-01 08:20:00 01/07/2021 | 52.42% |
| Buy | Numis | Premium Only | 2021-06-30 14:00:00 30/06/2021 | 108.48% |
Indivior (INDV) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Qube Research & Technologies Limited | 1.4% | 04/11/2025 |
| Citadel Advisors LLC | 0.53% | 26/09/2025 |
| Millennium Capital (DIFC) Limited | 1.03% | 22/07/2025 |
| Latest Bid : 1,248.00p | Latest Ask : 1,250.00p |
| High Today : 1,264.00p | Low Today : 1,230.00p |
| This Years High : 1,264.00p | This Years Low : 576.50p |
| Volume : 304,722 | MKT Cap : £1547.5M |
Indivior Overview
Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Indivior Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Sabah Meddings | Premium Only | 2021-10-24 09:30:00 24/10/2021 | -38.67% |
| Buy | Kevin Godbold | Premium Only | 2021-10-16 09:40:00 16/10/2021 | -45.82% |
| Buy | Jefferies | Premium Only | 2021-08-31 05:11:00 31/08/2021 | 33.78% |
| Buy | Royston Wild | Premium Only | 2021-07-01 08:20:00 01/07/2021 | 52.42% |
| Buy | Numis | Premium Only | 2021-06-30 14:00:00 30/06/2021 | 108.48% |